Dolores Schendel

Chief Executive Officer and Chief Scientific Officer, Medigene

Dolores has been a member of the German Research Foundation, German Cancer Aid and the European Research Council, and developed her interest in tumor immunology while working at the Sloan-Kettering Institute in New York. She joined Medigene as Chief Scientific Officer in 2014, when the company acquired Trianta Immunotherapy, and was appointed CEO in 2016.

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019